According to Atara Biotherapeutics's latest financial reports the company has -$99.24 M in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2022-12-31 | $0.12 B | -54.71% |
2021-12-31 | $0.27 B | -39.52% |
2020-12-31 | $0.46 B | 59% |
2019-12-31 | $0.29 B | -14.19% |
2018-12-31 | $0.33 B | 90.51% |
2017-12-31 | $0.17 B | -29.9% |
2016-12-31 | $0.25 B | -19.47% |
2015-12-31 | $0.31 B | 205.38% |
2014-12-31 | $0.10 B | -1036.57% |
2013-12-31 | $-11.02 M | 195.6% |
2012-12-31 | $-3.73 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
ImmunoGen
IMGN | $0.56 B | -665.95% | ๐บ๐ธ USA |
Agenus
AGEN | -$0.15 B | 49.53% | ๐บ๐ธ USA |
Affimed
AFMD | $63.91 M | -164.41% | ๐ฉ๐ช Germany |